IMMUNOREACTIVITY FOR BCL-2 PROTEIN IN MALIGNANT MESOTHELIOMA AND NONNEOPLASTIC MESOTHELIUM

被引：39
|
作者：
SEGERS, K
RAMAEL, M
KUMAR-SINGH, S
WEYLER, J
VANMEERBEECK, J
VERMEIRE, P
VANMARCK, E
机构：
[1] UNIV HOSP ANTWERP, DEPT PATHOL, B-2650 EDEGEM, BELGIUM
[2] UNIV INSTELLING ANTWERP, DEPT EPIDEMIOL & SOCIAL MED, B-2610 WILRIJK, BELGIUM
[3] UNIV HOSP ANTWERP, DEPT RESP MED, EDEGEM, BELGIUM
来源：
VIRCHOWS ARCHIV | 1994年 / 424卷 / 06期
关键词：
BCL-2; PROTEIN; MESOTHELIOMA; PLEURA; IMMUNOHISTOCHEMISTRY; PROGNOSIS;
D O I：
10.1007/BF01069743
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
Immunohistochemical study of bcl-2 protein immunoreactivity in human non-neoplastic mesothelium (44 cases) and in malignant mesothelioma (62 cases) using a murine monoclonal antibody (clone 124) showed cytoplasmic immunoreactivity for bcl-2 protein in five cases of malignant mesothelioma. Non-neoplastic mesothelium was not immunoreactive. Immunoreactivity for bcl-2 protein does not add useful prognostic information in malignant mesothelioma since survival times of bcl-2 positive and bcl-2 negative cases did not differ. Nevertheless, the detection of bcl-2 protein in malignant mesothelioma might be useful for the differentiation from reactive mesothelium.
引用
收藏
页码：631 / 634
页数：4
相关论文
共 50 条
  • [1] IMMUNOREACTIVITY FOR P53 PROTEIN IN MALIGNANT MESOTHELIOMA AND NONNEOPLASTIC MESOTHELIUM
    RAMAEL, M
    LEMMENS, G
    EERDEKENS, C
    BUYSSE, C
    DEBLIER, I
    JACOBS, W
    VANMARCK, E
    JOURNAL OF PATHOLOGY, 1992, 168 (04): : 371 - 375
  • [2] IMMUNOREACTIVITY FOR THE BETA-CHAIN OF THE PLATELET-DERIVED GROWTH-FACTOR RECEPTOR IN MALIGNANT MESOTHELIOMA AND NONNEOPLASTIC MESOTHELIUM
    RAMAEL, M
    BUYSSE, C
    VANDENBOSSCHE, J
    SEGERS, K
    VANMARCK, E
    JOURNAL OF PATHOLOGY, 1992, 167 (01): : 1 - 4
  • [3] Mesothelium and Malignant Mesothelioma
    Hiriart, Emilye
    Deepe, Raymond
    Wessels, Andy
    JOURNAL OF DEVELOPMENTAL BIOLOGY, 2019, 7 (02):
  • [4] Expression of the BCL-2 family in malignant pleural mesothelioma
    O'Kane, S
    Pound, R
    Campbell, A
    Lind, M
    Cawkwell, L
    LUNG CANCER, 2005, 49 : S225 - S225
  • [5] Expression of Bcl-2 family members in malignant pleural mesothelioma
    O'Kane, Sara L.
    Pound, Rachelle J.
    Campbell, Anne
    Chaudhuri, Nilanjan
    Lind, Michael J.
    Cawkwell, Lynn
    ACTA ONCOLOGICA, 2006, 45 (04) : 449 - 453
  • [6] IMMUNOHISTOCHEMICAL DISTRIBUTION PATTERNS OF EPIDERMAL GROWTH-FACTOR RECEPTOR IN MALIGNANT MESOTHELIOMA AND NONNEOPLASTIC MESOTHELIUM
    RAMAEL, M
    SEGERS, K
    BUYSSE, C
    VANDENBOSSCHE, J
    VANMARCK, E
    VIRCHOWS ARCHIV A-PATHOLOGICAL ANATOMY AND HISTOPATHOLOGY, 1991, 419 (03) : 171 - 175
  • [7] IMMUNOREACTIVITY FOR P-170 GLYCOPROTEIN IN MALIGNANT MESOTHELIOMA AND IN NONNEOPLASTIC MESOTHELIUM OF THE PLEURA USING THE MURINE MONOCLONAL-ANTIBODY JS']JSB-1
    RAMAEL, M
    VANDENBOSSCHE, J
    BUYSSE, C
    VANMEERBEECK, J
    SEGERS, K
    VERMEIRE, P
    VANMARCK, E
    JOURNAL OF PATHOLOGY, 1992, 167 (01): : 5 - 8
  • [8] BCL-2 IMMUNOREACTIVITY IN NEUROBLASTOMAS
    FURMAN, J
    SWANSON, PE
    COFFIN, CM
    DEHNER, LP
    LABORATORY INVESTIGATION, 1994, 70 (01) : A146 - A146
  • [9] IMMUNOREACTIVITY FOR C-FOS AND C-MYC PROTEIN WITH THE MONOCLONAL-ANTIBODIES 14EIO AND 6E10 IN MALIGNANT MESOTHELIOMA AND NONNEOPLASTIC MESOTHELIUM OF THE PLEURA
    RAMAEL, M
    VANDENBOSSCHE, J
    BUYSSE, C
    DEBLIER, I
    SEGERS, K
    VANMARCK, E
    HISTOLOGY AND HISTOPATHOLOGY, 1995, 10 (03) : 639 - 643
  • [10] IMMUNOREACTIVITY FOR BCL-2 PROTEIN IN CUTANEOUS LYMPHOMAS AND LYMPHOID HYPERPLASIAS
    TRISCOTT, JA
    RITTER, JH
    SWANSON, PE
    WICK, MR
    JOURNAL OF CUTANEOUS PATHOLOGY, 1995, 22 (01) : 2 - 10
12345